Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

Milestone Scientific, Inc. is a biomedical technology research and development company. The company is headquartered in Livingston, New Jersey and currently employs 16 full-time employees. The firm uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types. Milestone`s product portfolio includes Single Tooth Anesthesia Instrument (STA Instrument), CompuDent, CompuMed and The Wand. The firm`s STA Instrument is a computer-controlled local anesthesia delivery instrument that utilizes the pressure feedback elements of Milestone`s CompuFlo technology. CompuDent (also known as the Wand Plus internationally) is Milestone`s C-CLAD instrument. CompuMed is a computer-controlled injection instrument offered by the Company. The Wand handpiece is used in conjunction with the STA, CompuDent and CompuMed instruments.
Website: milestonescientific.com



Growth: Good revenue growth rate >200%, there is acceleration compared to average historical growth rates 16.7%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -68.8%. On average the margin is improving steadily. Gross margin is high, +74.6%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 83% of quarters (showing a gain of $0 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 12.0% higher than minimum and 77.7% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.9x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: MLSS
Share price, USD:  (0.0%)0.2969
year average price 0.6467  


year start price 1.2250 2025-02-10

max close price 1.2250 2025-02-10

min close price 0.2652 2026-01-21

current price 0.2969 2026-02-10
Common stocks: 68 432 307

Dividend Yield:  0.0%
EV / Sales: 1.1x
Margin (EBITDA LTM / Revenue): -68.8%
Fundamental value created in LTM:
Market Cap ($m): 20
Net Debt ($m): -3
EV (Enterprise Value): 17
Price to Book: 8.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-10-14globenewswire.com

Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership

2025-10-14globenewswire.com

Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification

2025-09-22globenewswire.com

Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management

2025-05-15globenewswire.com

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

2024-12-04globenewswire.com

Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024

2024-08-12globenewswire.com

Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call

2024-05-16seekingalpha.com

Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript

2024-05-13GlobeNewsWire

Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call

2024-03-28GlobeNewsWire

Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call

2023-08-15Seeking Alpha

Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683
fillingDate 2025-11-13 2025-08-14 2024-11-14 2024-08-14 2024-05-15 2023-09-30 2023-08-14 2023-05-10 2022-11-14 2022-08-15
acceptedDate 2025-11-13 16:01:23 2025-08-14 16:02:12 2025-04-15 16:01:07 2024-11-14 16:15:50 2024-08-14 16:00:32 2024-05-15 16:01:31 2024-03-29 13:44:09 2023-09-29 20:00:00 2023-08-14 16:02:22 2023-05-10 16:02:57 2023-03-30 17:09:47 2022-11-14 16:00:39 2022-08-15 16:00:41 2022-03-31 16:35:02 2021-03-31 16:05:47
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 2M 2M 9M 3M 2M 2M 10M 2M 3M 3M 9M 2M 2M 10M 5M
costOfRevenue 739 351 705 860 2M 677 585 442 560 584 424 3M 555 850 1M 708 135 4M 762 964 967 720 4M 2M
grossProfit 2M 2M 6M 2M 1M 2M 7M 2M 2M 2M 5M 1M 680 648 6M 4M
grossProfitRatio 0.687 0.696 0.73 0.761 0.74 0.73 0.65 0.727 0.656 0.413
researchAndDevelopmentExpenses 16 226 51 789 858 767 232 056 314 968 94 211 701 378 170 478 213 647 140 347 1M 166 191 266 560 878 210 307 850
generalAndAdministrativeExpenses 0 3M 0 0 0 0 0 0 391 000 0 0 0 0 0 0
sellingAndMarketingExpenses 0 78 110 0 0 0 0 0 0 4M 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 3M 3M 0 3M 3M 3M 0 3M 4M 3M 0 3M 3M 0 0
otherExpenses 0 19 496 12M 8574 8477 0 13M 0 0 17 220 13M 16 661 16 645 13M 11M
operatingExpenses 3M 3M 13M 3M 3M 3M 14M 3M 4M 3M 14M 3M 4M 14M 11M
costAndExpenses 3M 4M 15M 4M 4M 4M 17M 4M 5M 4M 18M 4M 5M 18M 13M
interestIncome 0 1521 60 265 8008 0 0 125 527 30 600 48 722 0 54 607 0 0 0 0
interestExpense 19 488 0 0 0 0 -3351 0 0 48 722 23 345 0 28 012 3550 16 360 18 081
depreciationAndAmortization 39 078 50 977 37 450 8574 31 524 36 148 62 319 39 339 39 728 39 798 63 843 76 359 33.443 73 835 95 949
ebitda -1M -1M -7M -1M -2M -1M -7M -1M -2M -1M -9M -2M -3M -7M -7M
ebitdaratio -0.464 -0.617 -0.581 -0.943 -0.635 -0.713 -0.769 -0.502 -0.874 -1.746
operatingIncome -1M -1M -7M -1M -2M -1M -7M -2M -2M -1M -9M -2M -3M -7M -7M
operatingIncomeRatio -0.481 -0.639 -0.584 -0.96 -0.651 -0.732 -0.783 -0.517 -0.909 -1.75
totalOtherIncomeExpensesNet -19 488 1521 2M 8008 2M 24 541 125 527 30 600 48 722 23 345 54 607 28 012 3550 502 409 79 806
incomeBeforeTax -1M -1M -5M -1M 223 638 -1M -7M -1M -2M -1M -9M -2M -3M -7M -7M
incomeBeforeTaxRatio -0.489 -0.638 -0.581 0.121 -0.641 -0.717 -0.766 -0.508 -0.896 -1.748
incomeTaxExpense 0 0 0 0 0 2 0 -9811 -12 511 -11 665 0 -41 692 -22 848 333 15 500
netIncome -1M -1M -5M -1M 223 638 -1M -7M -1M -2M -1M -9M -2M -3M -7M -7M
netIncomeRatio -0.489 -0.638 -0.581 0.121 -0.641 -0.712 -0.762 -0.503 -0.877 -1.734
eps -0.01 -0.018 -0.059 -0.018 0.003 -0.018 -0.095 -0.02 -0.031 -0.018 -0.12 -0.027 -0.041 -0.1 -0.12
epsdiluted -0.01 -0.018 -0.018 0.003 -0.018 -0.02 -0.031 -0.018 -0.027 -0.041
weightedAverageShsOut 82M 82M 80M 80M 80M 80M 73M 74M 72M 72M 71M 71M 70M 69M 63M
weightedAverageShsOutDil 82M 82M 80M 80M 80M 80M 73M 74M 72M 72M 71M 71M 70M 69M 63M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-04-15 2024-03-29 2023-03-30 2022-03-31 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 60 265 125 527 54 607 -16 360 -18 081
ebit -7M -7M -9M -7M -7M
nonOperatingIncomeExcludingInterest 0 0 0 0 0
netIncomeFromContinuingOperations -5M -7M -9M -7M -7M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -5M -7M -9M -7M -7M
epsDiluted -0.059 -0.095 -0.12 -0.1 -0.12

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683
fillingDate 2025-11-13 2025-08-14 2024-11-14 2024-08-14 2024-05-15 2023-09-30 2023-08-14 2023-05-10 2022-11-14 2022-08-15
acceptedDate 2025-11-13 16:01:23 2025-08-14 16:02:12 2025-04-15 16:01:07 2024-11-14 16:15:50 2024-08-14 16:00:32 2024-05-15 16:01:31 2024-03-29 13:44:09 2023-09-29 20:00:00 2023-08-14 16:02:22 2023-05-10 16:02:57 2023-03-30 17:09:47 2022-11-14 16:00:39 2022-08-15 16:00:41 2022-03-31 16:35:02 2021-03-31 16:05:47
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 1M 1M 3M 5M 6M 4M 3M 2M 4M 2M 9M 10M 11M 15M 14M
shortTermInvestments 0 0 0 0 0 1 000 000 3M 2M 2M 4M 0 0 0 0 0
cashAndShortTermInvestments 1M 1M 3M 5M 6M 5M 6M 5M 6M 7M 9M 10M 11M 15M 14M
netReceivables 716 536 690 630 475 376 550 969 386 836 2M 312 664 591 012 789 584 912 399 693 717 1M 825 346 943 272 1M
inventory 4M 4M 4M 4M 3M 3M 3M 2M 2M 2M 2M 2M 2M 2M 2M
otherCurrentAssets 2M 2M 564 645 2M 2M 863 589 1M 578 753 551 990 767 430 1M 478 218 2M 1M 414 202
totalCurrentAssets 8M 8M 9M 11M 11M 11M 11M 10M 11M 12M 13M 15M 16M 19M 19M
propertyPlantEquipmentNet 255 733 282 358 337 964 285 597 325 386 345 627 374 257 398 483 425 697 453 171 479 476 501 728 506 849 574 224 663 182
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 96 039 113 494 148 404 155 255 162 105 168 956 178 636 188 314 201 529 214 742 227 956 237 636 250 850 277 619 329 249
goodwillAndIntangibleAssets 96 039 113 494 148 404 155 255 162 105 168 956 178 636 188 314 201 529 214 742 227 956 237 636 250 850 277 619 329 249
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 24 150 24 149 24 150 35 415 24 150 24 149 24 150 24 150 24 150 24 150 24 150 24 150 41 086 24 150 24 150
totalNonCurrentAssets 375 922 420 001 510 518 476 267 511 641 538 732 577 043 610 947 651 376 692 063 731 582 763 514 798 785 875 993 1M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
totalAssets 8M 8M 10M 11M 12M 11M 11M 11M 11M 12M 14M 15M 17M 20M 20M
accountPayables 2M 2M 1M 1M 2M 2M 1M 1M 674 587 823 907 2M 1M 1M 1M 868 110
shortTermDebt 150 641 143 663 0 116 043 230 778 115 574 0 110 358 107 234 104 114 0 98 086 95 174 0 276 180
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 3M 2M 0 3M 1M 2M 0 2M 2M 2M 0 2M 2M 0 242 589
totalCurrentLiabilities 5M 4M 4M 4M 4M 4M 3M 3M 3M 3M 3M 4M 3M 3M 3M
longTermDebt 903 097 942 888 0 195 649 225 050 253 774 0 311 693 340 433 368 523 0 422 118 447 667 0 0
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 0 -1 0 0 0 -1 1 0 0 0 0 -958 689 0 0 1
totalNonCurrentLiabilities 903 097 942 887 220 245 195 649 225 050 253 773 282 288 311 693 340 433 368 523 395 977 422 118 447 667 497 042 586 589
otherLiabilities 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 253 738 286 551 349 054 311 692 340 439 253 774 395 978 422 051 447 667 472 637 497 043 520 204 542 841 586 588 666 415
totalLiabilities 6M 5M 4M 4M 4M 4M 3M 4M 3M 3M 4M 4M 4M 4M 3M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 78 592 78 592 78 048 77 710 77 228 76 632 75 881 70 894 70 108 69 806 69 306 68 907 68 811 68 153 64 171
retainedEarnings -133M -132M -128M -126M -125M -125M -123M -121M -120M -118M -116M -114M -112M -108M -101M
accumulatedOtherComprehensiveIncomeLoss 0 -0 0 0 0 -0 0 -0 0 0 -0 0 0 -0 0
othertotalStockholdersEquity 135M 135M 133M 132M 132M 129M 128M 127M 126M 125M
totalStockholdersEquity 3M 3M 6M 7M 8M 7M 8M 7M 8M 9M 10M 11M 13M 16M 16M
totalEquity 3M 3M 6M 7M 8M 8M 8M 7M 8M 9M 10M 11M 13M 16M 16M
totalLiabilitiesAndStockholdersEquity 8M 8M 11M 12M 11M 11M 11M 12M 15M 17M
minorityInterest 0 0 0 214 000 0 214 000 0 -253 263 -243 452 -230 941 -219 276 0 0 -152 541 -94 426
totalLiabilitiesAndTotalEquity 8M 8M 10M 11M 12M 11M 11M 11M 11M 12M 14M 15M 17M 20M 20M
totalInvestments 0 0 0 0 0 1 000 000 3M 2M 2M 4M 0 0 0 0 0
totalDebt 1M 1M 349 054 311 692 340 439 369 348 395 978 422 051 447 667 472 637 497 043 520 204 542 841 586 588 942 595
netDebt -291 563 -187 763 -3M -4M -5M -4M -3M -2M -3M -2M -8M -9M -10M -14M -13M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-04-15 2024-03-29 2023-03-30 2022-03-31 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 475 376 312 664 693 717 943 272 1M
otherReceivables 0 0 0 0 0
prepaids 1M 517 785 443 872 375 360 415 915
totalPayables 2M 1M 2M 1M 868 110
otherPayables 493 313 0 0 0 0
accruedExpenses 2M 2M 1M 2M 1M
capitalLeaseObligationsCurrent 128 809 113 691 101 066 89 546 79 827
capitalLeaseObligationsNonCurrent 220 245 282 287 395 977 497 042 586 588
treasuryStock -911 516 -911 516 -911 516 -911 516 -911 516
additionalPaidInCapital 135M 132M 127M 125M 118M
otherTotalStockholdersEquity 0 -1 0 0 -1

Cash Flow Statement

Property 2025 q2 2025 q1 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS MLSS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683 855 683
fillingDate 2025-08-14 2025-05-15 2024-11-14 2024-08-14 2024-05-15 2023-09-30 2023-08-14 2023-05-10 2022-11-14 2022-08-15
acceptedDate 2025-08-14 16:02:12 2025-05-15 16:01:13 2025-04-15 16:01:07 2024-11-14 16:15:50 2024-08-14 16:00:32 2024-05-15 16:01:31 2024-03-29 13:44:09 2023-09-29 20:00:00 2023-08-14 16:02:22 2023-05-10 16:02:57 2023-03-30 17:09:47 2022-11-14 16:00:39 2022-08-15 16:00:41 2022-03-31 16:35:02 2021-03-31 16:05:47
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome -1M -2M -5M 1M 223 638 -1M -7M -1M -2M -1M -9M -2M -5M -7M -7M
depreciationAndAmortization 50 977 45 315 134 843 33 212 31 524 36 148 150 362 39 339 39 728 39 798 144 376 76 359 33 443 73 835 95 949
deferredIncomeTax 0 0 0 0 0 0 0 131 443 0 0 0 0 0 -518 769 -97 887
stockBasedCompensation 159 678 624 338 2M -786 148 207 690 578 458 2M 370 326 621 829 438 772 2M 400 203 697 165 2M 1M
changeInWorkingCapital -701 505 316 844 -631 000 199 603 230 773 -430 376 -1M -515 349 486 947 -1M -549 723 101 942 268 486 1M -2M
accountsReceivables -174 185 -49 594 -162 712 398 744 0 -398 744 309 942 182 496 122 815 -218 682 249 555 -96 410 118 316 137 384 630 009
inventory 262 479 -446 281 -1M 221 843 0 -221 843 -1M -398 726 -154 765 -245 963 -833 121 -46 407 430 503 878 666 -799 670
accountsPayables -723 149 1M 414 590 -1M 323 069 794 781 -806 106 484 627 25 798 -630 742 729 936 34 657 604 011 308 175 -2M
otherWorkingCapital -66 650 -351 764 192 151 696 866 -92 296 -604 570 199 555 -783 746 493 099 -193 440 -696 093 210 102 0 -257 230 227 727
otherNonCashItems 209 776 0 579 801 -2M 90 030 514 731 968 157 397 142 56 786 126 000 1M 265 684 0 652 765 2M
netCashProvidedByOperatingActivities -2M -1M -3M -973 914 783 655 -1M -5M -1M -1M -2M -6M -1M -4M -4M -7M
investmentsInPropertyPlantAndEquipment -4472 -1304 -10 124 6596 -6596 0 -4881 4 -4 -1192 -8527 0 0 -15 189 -21 438
acquisitionsNet 0 0 0 0 0 0 3M -4M 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 -8M -5M 2M -4M 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 3M -3M 972 110 2M 5M 4M 0 0 0 0 0 0 0
otherInvestingActivites 0 0 0 0 2M 4M 0 0 -3912 85
netCashUsedForInvestingActivites -4472 -1304 0 965 514 2M -475 494 2M -4M -3912 85
debtRepayment 796 583 -2278 -2595 -2540 -2478 -2162 -2162 -2162 -2252 -4231.937
commonStockIssued 0 0 -192 156 0 243 907 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 0 0 0 241 429 0 0 0 0 0
netCashUsedProvidedByFinancingActivities 796 583 -2278 -2595 -2540 241 429 -2162 -2162 -2162 -2252 -4231.937
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
netChangeInCash -972 073 -1M 280 345 -976 509 2M 1M -6M -2M 1M -6M -6M -1M -2M 540 429 13M
cashAtEndOfPeriod 1M 2M 3M 5M 6M 4M 3M 2M 4M 2M 9M 10M 11M 15M 14M
cashAtBeginningOfPeriod 2M 3M 3M 6M 4M 3M 9M 4M 2M 9M 15M 11M 13M 14M 2M
operatingCashFlow -2M -1M -3M -973 914 783 655 -1M -5M -1M -1M -2M -6M -1M -4M -4M -7M
capitalExpenditure -4472 -1304 -10 125 6596 -6596 0 -4881 4 -4 -1192 -8527 0 0 -15 189 -21 438
freeCashFlow -2M -1M -3M -967 318 777 059 -1M -5M -1M -1M -2M -6M -1M -4M -4M -7M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-04-15 2024-03-29 2023-03-30 2022-03-31 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 -3M 0 0 0
netCashProvidedByInvestingActivities 3M -3M -8527 -15 189 -21 438
netDebtIssuance -10 136 -9366 -8544 -8648 268 558
longTermNetDebtIssuance -10 136 -9366 -8544 -8648 268 558
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 192 156 3M 0 0 0
netCommonStockIssuance 192 156 3M 0 0 18M
commonStockIssuance 192 156 3M 0 5M 18M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 51 751 0 0 5M 19M
netCashProvidedByFinancingActivities 233 771 3M -8544 5M 20M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-11-14 ET (fiscal 2025 q3)
2024 q3
2024-11-15 ET (fiscal 2024 q3)
2024 q2
2024-08-15 ET (fiscal 2024 q2)
2024 q1
2024-05-16 ET (fiscal 2024 q1)
2023 q4
2024-04-01 ET (fiscal 2023 q4)
2023 q3
2023-11-15 ET (fiscal 2023 q3)
2023 q2
2023-08-15 ET (fiscal 2023 q2)
2023 q1
2023-05-11 ET (fiscal 2023 q1)
2022 q4
2023-03-31 ET (fiscal 2022 q4)
2022 q3
2022-11-15 ET (fiscal 2022 q3)
2022 q2
2022-08-16 ET (fiscal 2022 q2)
2022 q1
2022-05-17 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-13 16:01 ET
Milestone Scientific reported for 2025 q3
SEC form 10
2025-08-14 20:02 ET
Milestone Scientific reported for 2025 q2
SEC form 10
2025-05-15 20:01 ET
Milestone Scientific reported for 2025 q1
SEC form 10
2025-05-15 00:00 ET
Milestone Scientific reported for 2025 q1
SEC form 8
2025-04-22 20:10 ET
Milestone Scientific published news for 2025 q1
SEC form 8
2025-04-22 20:10 ET
Milestone Scientific published news for 2025 q1
SEC form 10
2025-04-15 20:01 ET
Milestone Scientific reported for 2024 q4
SEC form 10
2025-04-15 00:00 ET
Milestone Scientific reported for 2024 q4
SEC form 10
2024-11-14 16:15 ET
Milestone Scientific reported for 2024 q3
SEC form 10
2024-11-14 00:00 ET
Milestone Scientific reported for 2024 q3
SEC form 10
2024-08-14 16:00 ET
Milestone Scientific reported for 2024 q2
SEC form 10
2024-08-14 00:00 ET
Milestone Scientific reported for 2024 q2
SEC form 10
2024-05-15 16:01 ET
Milestone Scientific reported for 2024 q1
SEC form 10
2024-05-15 00:00 ET
Milestone Scientific reported for 2024 q1
SEC form 10
2024-03-29 13:44 ET
Milestone Scientific reported for 2023 q4
SEC form 10
2024-03-29 00:00 ET
Milestone Scientific reported for 2023 q4
SEC form 10
2023-11-14 16:00 ET
Milestone Scientific reported for 2023 q3
SEC form 10
2023-11-14 00:00 ET
Milestone Scientific reported for 2023 q3
SEC form 10
2023-08-14 16:02 ET
Milestone Scientific reported for 2023 q2
SEC form 10
2023-08-14 00:00 ET
Milestone Scientific reported for 2023 q2
SEC form 6
2023-07-13 10:11 ET
Milestone Scientific published news for 2023 q2
SEC form 6
2023-06-30 16:00 ET
Milestone Scientific published news for 2023 q1
SEC form 10
2023-05-10 16:02 ET
Milestone Scientific reported for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Milestone Scientific reported for 2023 q1
SEC form 6
2023-05-01 17:20 ET
Milestone Scientific published news for 2023 q1
SEC form 10
2023-03-30 17:09 ET
Milestone Scientific reported for 2022 q4
SEC form 10
2023-03-30 00:00 ET
Milestone Scientific reported for 2022 q4
SEC form 6
2023-02-06 15:45 ET
Milestone Scientific published news for 2022 q4
SEC form 6
2023-01-05 08:00 ET
Milestone Scientific published news for 2022 q4
SEC form 6
2022-12-07 15:17 ET
Milestone Scientific published news for 2022 q3
SEC form 10
2022-11-14 16:00 ET
Milestone Scientific reported for 2022 q3
SEC form 10
2022-11-14 00:00 ET
Milestone Scientific reported for 2022 q3
SEC form 6
2022-10-18 17:18 ET
Milestone Scientific published news for 2022 q3
SEC form 10
2022-08-15 16:00 ET
Milestone Scientific reported for 2022 q2
SEC form 10
2022-08-15 00:00 ET
Milestone Scientific reported for 2022 q2
SEC form 6
2022-06-14 16:18 ET
Milestone Scientific published news for 2022 q1
SEC form 10
2022-05-16 16:35 ET
Milestone Scientific reported for 2022 q1
SEC form 10
2022-05-16 00:00 ET
Milestone Scientific reported for 2022 q1
SEC form 6
2022-05-03 08:00 ET
Milestone Scientific published news for 2022 q1
SEC form 6
2022-04-29 16:01 ET
Milestone Scientific published news for 2022 q1
SEC form 10
2022-03-31 16:35 ET
Milestone Scientific published news for 2021 q4
SEC form 10
2022-03-31 00:00 ET
Milestone Scientific published news for 2021 q4
SEC form 6
2022-01-20 11:30 ET
Milestone Scientific published news for 2021 q4
SEC form 6
2021-12-10 16:02 ET
Milestone Scientific published news for 2021 q3
SEC form 10
2021-11-12 16:38 ET
Milestone Scientific published news for 2021 q3
SEC form 10
2021-11-12 00:00 ET
Milestone Scientific published news for 2021 q3
SEC form 10
2021-08-13 16:19 ET
Milestone Scientific published news for 2021 q2
SEC form 10
2021-08-13 00:00 ET
Milestone Scientific published news for 2021 q2
SEC form 6
2021-07-02 07:30 ET
Milestone Scientific published news for 2021 q2
SEC form 6
2021-06-17 09:28 ET
Milestone Scientific published news for 2021 q1
SEC form 10
2021-05-14 16:00 ET
Milestone Scientific published news for 2021 q1
SEC form 10
2021-05-14 00:00 ET
Milestone Scientific published news for 2021 q1
SEC form 6
2021-04-30 16:00 ET
Milestone Scientific published news for 2021 q1
SEC form 6
2021-04-09 17:03 ET
Milestone Scientific published news for 2021 q1
SEC form 6
2021-04-07 15:14 ET
Milestone Scientific published news for 2021 q1
SEC form 10
2021-03-31 16:05 ET
Milestone Scientific published news for 2020 q4
SEC form 6
2021-03-24 17:10 ET
Milestone Scientific published news for 2020 q4
SEC form 6
2021-03-03 15:12 ET
Milestone Scientific published news for 2020 q4
SEC form 6
2020-12-11 11:10 ET
Milestone Scientific published news for 2020 q3
SEC form 6
2020-11-30 17:22 ET
Milestone Scientific published news for 2020 q3
SEC form 10
2020-11-16 16:15 ET
Milestone Scientific published news for 2020 q3
SEC form 6
2020-10-26 16:48 ET
Milestone Scientific published news for 2020 q3
SEC form 6
2020-10-09 16:22 ET
Milestone Scientific published news for 2020 q3